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The hormone regulation of viruses has been of great interest since the discovery of glucocorticoid stimulation of mouse
mammary tumor virus via a hormone response element in the viral long terminal repeat (LTR) promoter region. This report
describes the investigation of the hormone responsiveness of bovine leukemia virus (BLV), an oncogenic retrovirus that
infects dairy and beef cattle worldwide. It is a member of the human T cell leukemia (HTLV)/BLV group of retroviruses,
which encode a protein, Tax, that is essential for regulating transcription of their own proviruses and for transforming host
cells. We investigated the responsiveness of BLV to the hormones 17b-estradiol, progesterone, prolactin, insulin, and
dexamethasone, a potent glucocorticoid. Only dexamethasone, in combination with insulin or insulin/prolactin, consistently
stimulated BLV expression, as measured by reverse transcriptase activity, RNA blot hybridization (Northern blots), and CAT
(chloramphenicol acetyltransferase) reporter assays of cell lines transiently or stably transfected with the BLV LTR. This
effect required the presence of glucocorticoid receptors and Tax. This is the first report of hormone responsiveness in a
virus of the HTLV/BLV group. q 1997 Academic Press
Hormone regulation of viruses has been of great inter- levels of estrogen and progesterone during pregnancy
est since the discovery of glucocorticoid stimulation of and the sharp peak of glucocorticoids toward the end of
mouse mammary tumor virus (MMTV) replication and term (reviewed, Cowie et al., 1980) suggested that these
release (McGrath, 1971; Parks et al., 1974; Smoller et mammotropic hormones might be responsible for the
al., 1961), an effect potentiated by insulin and prolactin increased viral replication, either directly or indirectly.
(Bolander and Blackstone, 1990; Mun˜oz and Bolander, Although MMTV infects both mammary epithelial cells
1989; Nagle and Fine, 1978; Yang et al., 1977). Glucocorti- and lymphocytes (Ball et al., 1985), its replication is pri-
coid induction of MMTV was indicated more directly by marily in the mammary epithelial cells during lactation,
an increase in viral RNA within cells treated with dexa- and in this way it is passed to the next generation during
methasone, a potent synthetic glucocorticoid (Ringold et suckling.
al., 1975), and by the discovery that this virus had a We were interested in exploring the hormone respon-
hormone response element (HRE). This is a short se- siveness of bovine leukemia virus (BLV), an exogenous
quence within the promoter region of a gene, which oncogenic retrovirus which infects dairy and beef cattle
allows specific hormone receptors to bind and govern worldwide and is transmitted horizontally, primarily
transcription. One type of HRE, the glucocorticoid re- through the use of blood-contaminated farm and veteri-
sponse element (GRE), was first identified in MMTV, in nary instruments but also from cow to calf via milk (re-
the promoter region called the long terminal repeat (LTR), viewed, Kettman et al., 1994). BLV belongs to the human
and was proven to act as a transcriptional enhancer, T cell leukemia (HTLV)/BLV group which possesses the
regulated by glucocorticoid hormone–receptor com- usual retroviral genes, gag, pol, and env, flanked by two
plexes (Chandler et al., 1983; Payvar et al., 1983). Further identical long terminal repeat (LTR) promoter regions. In
studies showed that the same element could also medi- addition, this group has a unique pX region between the
ate progesterone, androgen, and mineralocorticoid re- env gene and the 3* LTR which codes for a regulatory
sponses (Arriza et al., 1987; Cato et al., 1987; Van der factor, Tax. This protein, believed to be responsible for
Ahe et al., 1985). the oncogenic potential of BLV, also stimulates viral tran-
The hormone responsiveness of MMTV might have scription by interacting with a cyclic AMP response ele-
been predicted by various aspects of the virus’s life cycle. ment binding protein (CREB) at one of the three cAMP
The increased antibody titers to MMTV in infected mice response elements (CRE) in the LTR (Willems et al., 1992).
shortly after parturition suggested increased replication The primary target cell for BLV is the B lymphocyte,
of the virus (reviewed, Blair, 1981). The rise in plasma and in 5% of infected cows viral infection ultimately
leads to a B cell lymphoma/leukemia. BLV has also been
found in endothelial cells (Rovnak et al., 1991), T cells1 To whom correspondence should be addressed. Fax: (510) 642-
6350. (Stott et al., 1991), and mammary epithelial cells (Bueh-
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ring et al., 1994). Although in vivo replication of BLV in Immunocytochemistry
peripheral blood lymphocytes appears to be suppressed
Replicate cultures of C-761 cells (5000 cells per well)by a nonimmunoglobulin plasma protein (Zandomeni et
were seeded into wells of a 96-well culture plate. Afteral., 1992), in vivo antigen expression has been detected
attachment, the medium was changed and hormonesin lymphocytes of lymph nodes (Heeney and Valli, 1990)
(insulin, hydrocortisone, prolactin combination) or vehicleand in mammary epithelial cells (Buehring et al., 1994).
control (absolute ethanol, 1 mg/ml) added. After 48 h incu-Levels of antibody to BLV rise within 1 month after parutri-
bation, cells were fixed in methanol with 1% hydrogention (Burridge et al., 1982; Ebertus et al., 1987; Kuzmak,
peroxide (to expend endogenous peroxide) and assayed1988), subsequent to a sharp peak in plasma levels of
for BLV using an avidin–biotin–immunoperoxidaseglucocorticoids at parturition (reviewed, Cowie et al.,
assay (Vector Laboratories, Burlingame, CA). The primary1980). This similarity to MMTV coupled with the similarity
antibody was a mouse monoclonal to the BLV p24 anti-of milk transmission led us to question whether BLV
gen (Kramme et al., 1994). The chromagen was diamino-might also be regulated by mammotropic hormones. We
benzidine. Only cells with clearly defined dark stainingreport here an investigation of BLV’s responsiveness to
granules as described and pictured previously (Buehring17b-estradiol, progesterone, insulin, prolactin, and the
et al., 1994) were counted as positive.glucocorticoid, dexamethasone. Our methods of analysis
were immunocytochemistry, reverse transcriptase activ-
Reverse transcriptase (RT) assaysity, RNA blot hybridization, and chloramphenicol acetyl-
transferase (CAT) reporter assays of BLV-LTR promoter Equal inocula of cells were seeded into plastic culture
function. flasks (75 cm2) at a density adjusted to maintain the
optimal condition for virus production, i.e., a subconfluent
monolayer. The cells were then incubated in media withMATERIALS AND METHODS
or without added hormones for 96 h. The RT method was
Cells and virus that of Lee et al. (1987) modified from Hoffman et al.,
(1985). Spent media were clarified at 12,000 g for 10 min
Cell lines used were human mammary epithelial ade- and the virus pelleted by ultracentrifugation at 192,000 g
nocarcinoma, MCF-7 (Soule et al., 1973), demonstrated for 45 min, resuspended in lysing solution (50 mM Tris–
to have estrogen, progesterone, and glucocorticoid re- HCl, 5 mM dithiothreitol, 5 mM MgCl2 , 150 mM KCl, 0.5
ceptors (Horwitz et al., 1975); glucocorticoid-sensitive rat mM ethyleneglycoltetraacetic acid, 0.3 mM glutathione,
hepatoma line (BDS1) and its glucocorticoid receptor 0.05% Triton X-100), and stored at 47C for 24 h. A 1:1
negative mutant (EDR3) (Cook et al., 1988); a normal bat mixture of each sample and tritium-labeled reaction
lung epithelial line (Tb1Lu) and its BLV-infected subline buffer (lysing solution plus 60 mg/ml poly(rArdT) and 20
(Bat2Cl6) (Graves and Ferrer, 1976); BLV-infected fetal mCi/ml [3H]deoxythymidine) was incubated at 377C for 20
lamb kidney cells (FLK) (Van Der Maaten and Miller, h. This incubation time, longer than the 1-h time routinely
1976); and primary cultures of bovine mammary epithelial used for RT assays, was found to yield a much higher
cells isolated by collagenase/hyaluronidase digestion level of human immunodeficiency virus RT activity (Lee
(McGrath, 1987) of a mammary gland explant from cow C- et al., 1987) and of BLV RT activity (Billings and Buehring,
761. Cells were grown at 377C and 5% CO2 in Dulbecco’s pers. commun.). Trichloroacetic acid (10%)-precipitable
modified Eagle’s (DME) medium (GIBCO, Grand Island, material was vacuum collected onto glass fiber filters
NY) for all experiments. Medium for FLK cells was sup- and rinsed. The dried filters were scintillation counted.
plemented with 5% heat-inactivated fetal bovine serum Counts per minute were divided by the number of cells
(FBS) (Sigma, St. Louis, MO) medium for all other lines in the corresponding flask (previously counted by hemo-
with 10% FBS. cytometer after removal from the flask by trypsinization).
Hormones Northern (RNA) blot analysis
Cells were harvested by trypsinization, and total RNAThe hormones used in these experiments were added
to media to the following final concentrations: dexameth- was isolated from the cells using guanidine isothiocya-
nate lysis as described by Chomczynski and Sacchiasone (0.3 mg/ml; 1 1 1006 M), hydrocortisone 5 mg/ml;
1.4 1 1005 M), 17b-estradiol (0.1 mg/ml; 3.7 1 1007 M), (1987). RNA blot analysis was performed essentially as
described by Sambrook et al. (1989, pp. 7.43–7.48). Theprogesterone (5 mg/ml; 1.4 1 1005 M), prolactin (5 mg/
ml; 0.1–0.25 U/ml), and insulin (10 mg/ml; 1.7 1 1006 concentration of the RNA samples was determined spec-
trophotometrically (Shimadzu UV160, Pleasanton, CA)M). Choice of these concentrations was based on what
others had found effective in MMTV studies (Cardiff et and equal weights of RNA were loaded and electropho-
resed through a 1% agarose–Mops–formaldehyde gelal., 1976; McGrath, 1971; Parks et al., 1974; Ringold et
al., 1975; Yang et al., 1977). in Mops buffer, transferred to nitrocellulose, and fixed to
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the membrane with UV light. The blot was stained with nique (Felgner et al., 1987). Briefly, cells were grown in
60-mm dishes until about 75% confluent, incubated in0.02% methylene blue and photographed as a reference
for degree of loading uniformity. Approximately 100 ng antibiotic-free, serum-free medium with plasmids and
Lipofectamine (GIBCO, No. 18324-012) for 5 h and thenof purified BLV DNA cut from a plasmid containing the
whole BLV genome (kindly provided by James Casey of incubated overnight with serum added to a final cocen-
tration of 10%. Transiently transfected cells were thenCornell University, Ithaca, NY) was labeled with [32P]-
dCTP using a random priming kit (DuPont/NEN, Boston, rinsed and incubated in experimental hormone-con-
taining media. For stable transfectants, cells were co-No. 112L). After prehybridization (41 SSCP, 11 Den-
hardt’s solution, 1% sodium dodecyl sulfate (SDS), 100 transfected with the pSV2-Neo plasmid (at 0.1 the con-
centration of the other plasmid) to confer neomycin resis-mg/ml salmon sperm DNA) for 4–5 h at 657C, the mem-
brane was incubated overnight at 657C, with gentle shak- tance and then maintained for 2–3 weeks in neomycin
selection medium (Geneticin, GIBCO; 600 mg/ml) untiling in hybridization solution (41 SSPE, 1% SDS, 100 mg/
ml salmon sperm DNA, 10% sodium dextran sulfate, 11 apparent colonies began to appear and all cells in the
control (untransfected) culture had died. Colonies wereDenhardt’s solution) containing the labeled probe, and
then washed 21 for 20 min first in 11 SSCP, 0.1% SDS selectively trypsinized and grown in neomycin mainte-
nance medium (200 mg/ml) for 4 weeks and then testedat room temperature and then in 0.11 SSCP, 0.1% SDS
at 657C. Film (Hyperfilm-MP, Amersham) was exposed for CAT activity (see below) as a verification of successful
transfection of the BLV–LTR–CAT plasmid.to the blot at0707C and developed. The blot was washed
to strip it of BLV probe and then rehybridized with a
[32P]dCTP-labeled DNA probe for murine beta-actin
CAT assays
(kindly provided by T. Abrams, S. Nandi Lab, University
of California, Berkeley). Bands of each autoradiogram Both transient and stable transfectants were grown in
and methylene blue stained blots were quantitated by 60-mm culture dishes and incubated 48 h in experimental
scanning with an imaging densitometer system (Bio-Rad, media. Cell extracts were prepared by pouring off experi-
Richmond, CA, No. GS-670). mental medium, scraping the monolayer into DPBS, rins-
ing several times in DPBS, and lysing by either the
Protein synthesis determination freeze–thaw method described by Sambrook et al. (1989,
pp. 16.59–16.60) or the lysing solution provided by theCycloheximide inhibition of protein synthesis was de-
CAT ELISA kit (Boehringer-Mannheim, Indianapolis, IN).termined using Bat2Cl6 cells. Subconfluent monolayers
Cell debris was pelleted at 12,000 g for 5 min and thewere rinsed 21 with Dulbecco’s phosphate buffered sa-
supernatants were transferred to new microfuge tubes.line (DPBS) and incubated in leucine-free DME with 10%
Total protein was determined using either the Bio-RadFBS, dexamethasone, and insulin at 377C. Half of the
protein assay (Bio-Rad) or the BCA protein assay (Pierce,cultures were also treated with cycloheximide (10 mg/
Rockford, IL). To determine the CAT level in each sample,ml). After 30 min, [3H]leucine (100 mCi per dish) was
the diffusion–scintillation method described by Sam-added to all cultures and they were incubated 16 h at
brook et al. (1989, pp. 16.64–16.65) was used for tran-377C. Cells were then rinsed 31 with DPBS, scraped into
sient transfections. Briefly, cell extracts in 50-ml aliquotsDPBS, counted on a hemocytometer, and solubilized in
were mixed with 25 ml 1 M Tris–Cl, 50 ml 5 mM chloram-1 ml TETD-N250 detergent (25 mM Tris–HCl, pH 7.5; 5
phenicol, 0.1 mCi [3H]acetyl coenzyme A, and double dis-mM EDTA, pH 7.5; 250 mM NaCl; 1% Triton X-100; 0.5%
deoxycholate). After clarification, 10 ml of each superna- tilled water to a total of 250 ml in scintillation tubes and
tant was spotted on Whatman GFC filters and precipi- overlaid with 5 ml Fluoralloy (Beckman), a toluene-based
tated with 10% TCA/30 mM leucine (four rinses) and 10% scintillation fluid, and emissions were measured on a
TCA (one rinse). Dried filters were counted on a scintilla- scintillation counter. CAT activity of stable transfectants
tion counter, and the counts were divided by the number was analyzed using a CAT ELISA kit (Boehringer-Mann-
of cells in the corresponding flask. heim) according to manufacturer’s instructions.
Plasmids and transfections
Statistical analysis
The BLV–LTR–CAT and BLVpSGtax constructs (Wil-
For the RT assays, Northern blotting, and CAT assays,lems et al., 1990) were a gift from Luc Willems, Faculty
differences between the various hormone conditions andof Agronomy, Gembloux, Belgium, and the pSV2-Neo
the untreated controls were analyzed by the Dunnett tplasmid (Southern and Berg, 1982) was a gift from Arse`ne
test. This is a multiple comparison method which usesBurny, Free University of Brussels, Brussels, Belgium.
a pooled standard deviation and allows the comparisonThe Bluescribe plasmid (Stratagene, La Jolla, CA) was
of multiple values to a single control. The minimum signif-used as the mock control in transient transfections.
Transfections were performed using the lipofection tech- icance level was P  0.05, two-sided test.
AID VY 8868 / 6a54$$$502 12-15-97 10:27:05 vira AP: VY
252 NIERMANN AND BUEHRING
RESULTS
Hydrocortisone with insulin and prolactin increases
the frequency of BLV antigen-positive cells as
measured by immunocytochemistry
Table 1 summarizes these experiments and indicates
that this hormone combination increased the frequency
of BLVp24-positive bovine mammary epithelial cells.
This provided the first clue that BLV might be hormone
responsive.
Dexamethasone with insulin and prolactin increases
viral particle production as measured by reverse
transcriptase (RT) assay
In these experiments, RT activity of extracellular parti-
cles was used as a measure of BLV virion production
and was performed as the next step in determining which
mammotropic hormones might affect BLV production.
The effects of 17b-estradiol, progesterone, prolactin, in-
FIG. 1. Effect of hormones on BLV virion production as measuredsulin, and dexamethasone were tested using a cell line
by reverse transcriptase activity of extracellular particles. Cultures ofthat is a stable, long-term producer of BLV (Bat2Cl6) in a BLV-infected cell line (Bat2Cl6) were incubated under various hormone
order to have enough cells to test all hormones in multi- conditions. NH, no hormone; E2, 17b-estradiol; Pg, progesterone; Prl,
ple experiments. The effects of the hormone treatments prolactin; Ins, insulin; Dx, dexamethasone; *, statistically significant at
P  0.01, and /, at P  0.05, when compared to the NH controlare summarized in Fig. 1. Significant increase in RT activ-
(Dunnett t test). Error bars represent standard deviation from the meanity was noted in cells treated with progesterone, and
of triplicate samples.dexamethasone with insulin or insulin and prolactin.
These results were consistently obtained in three sepa-
rate experiments.
grams consistently demonstrated in nine separate exper-
iments an apparent increase in expression of BLV mRNADexamethasone with insulin and prolactin stimulates
by cells grown in combinations of dexamethasone/insu-viral mRNA transcription as measured by RNA blot
lin and dexamethasone/insulin/prolactin (Fig. 2). To con-hybridization
firm this visual impression, quantitative values for the
RNA extracts of the same BLV-infected cells used for bands on two of the autoradiograms were obtained as
the RT assays were analyzed by RNA blot (Northern blot) optical density (OD) measurements, using an imaging
hybridization to determine if the significant effects ob- densitometer. The bands representing the full-length
served with the RT assays were related to increased message at 8.4 kb (Fig. 2, arrow) were used for these
transcription rate or merely represented an increased measurements, as the signals corresponding to mes-
release of already synthesized virus particles. Purified sages at 4.4 and 2.0 kb were partially blocked by ribo-
RNA from cells treated with dexamethasone, insulin, pro- somal RNA molecules (4.8 and 1.9 kb, respectively). The
gesterone, and combinations of dexamethasone, insulin, OD value of each BLV mRNA sample was adjusted for
and prolactin were selected for testing. The autoradio- loading variation by normalizing to its corresponding OD
value from the actin probed blot. The results indicated
that neither progesterone, insulin, or dexamethasone
TABLE 1 alone had any effect on BLV mRNA levels, while dexa-
Effect of Hormones on Expression of the BLVp24 Antigen in methasone with insulin or insulin/prolactin significantly
Primary Cultures of Bovine Mammary Epithelial Cells (C-761) (P ¡ 0.05) increased BLV transcription (Fig. 3). These
results were consistent in two separate experiments.
Hormone condition
Since steroids have been found to alter transcription of
the actin gene (Anderson et al., 1988; Cicatiello et al.,No hormone Insulin/prolactin/
Experiment (vehicle control)a hydrocortisonea 1992), values were also normalized to methylene blue
stained blots. These showed the same trends.
1 5.6 { 0.6 19.4 { 1.9 To determine whether hormone effects on mRNA tran-
2 4.1 { 2.5 14.7 { 8.4
scription were primary (requiring no synthesis of an inter-
mediary protein) or secondary (requiring protein synthe-a Percentage cells positive out of at least 100 cells counted in each
replicate culture. Each value is the mean of two to three replicates. sis), cultures were treated with dexamethasone/insulin
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tritiated leucine. Protein synthesis in the cycloheximide
treated cells was reduced to 0.011 that of the control.
Collectively, these RNA blot analyses suggest that the
stimulatory effect of dexamethasone/insulin is at the tran-
scriptional level.
Dexamethasone effects are mediated via the BLV-
LTR, as measured by a CAT reporter system
We examined the role of the LTR in hormone regulation
of BLV, using the BLV-infected Bat2Cl6 cell line stably
transfected with a plasmid containing the BLV-LTR cou-
pled to a CAT reporter gene and a pRSV-neo plasmid
to confer neomycin resistance. Cells were grown under
various hormone conditions and assayed for CAT activity.
Statistically significant increases in CAT activity occurred
in cultures treated with progesterone alone, and dexa-
methasone/insulin, and dexamethasone/insulin/prolac-
tin combinations (Fig. 4). To confirm that these results
were not an artifact of the cell line used, parallel transient
transfection experiments were carried out in the BLV-
infected cell line, FLK, and responses to dexamethasone
and insulin tested. The LTR–CAT construct was signifi-
cantly stimulated by the dexamethasone/insulin combi-
nation (data not shown).
Dexamethasone/insulin stimulation requires the
presence of the BLV Tax
To further rule out a possible cell line effect, we tran-
siently transfected the same BLV–LTR–CAT plasmid into
MCF-7 mammary epithelial cells, not infected with BLV,
which were then grown under the same experimental
hormone conditions and assayed for CAT activity. To our
surprise, none of the cultures grown in any of the five
hormones tested (17b-estradiol, progesterone, prolactin,
insulin, and dexamethasone) alone or in combination,
had significant CAT activity above the control without
FIG. 2. Effect of hormones on BLV transcription as measured by RNA hormones. However, when a plasmid containing the BLV
blotting. Cultures of a BLV-infected cell line, Bat2Cl6 (BAT) were incubated tax was cotransfected, dexamethasone/insulin signifi-under various hormone conditions. NH, no hormone; DEX, dexametha-
cantly increased CAT activity relative to the no hormonesone; INS, insulin; PRL, prolactin; PG, progesterone; Tb1Lu, uninfected
parental line of Bat2Cl6 . Numbers on the y axis represent length in kilo- control level (Table 2). These results were obtained in at
bases. (A) Autoradiograph of an RNA blot hybridization. Arrows points to least three separate experiments. To determine if serum
bands corresponding to transcripts of the BLV genome: 8.4 kb, the full- factors were indirectly causing the stimulation, the exper-
length transcript of the BLV genome; 4.4 kb, the env transcript; 2.0 kb,
iment with MCF-7 cells was repeated under serum-freethe tax/rex transcript. (B) Corresponding methylene blue stained blot to
conditions. Cell growth was less vigorous, but the sameindicate eveness of loading and (C) actin-probed blot to represent global
transcription levels. effect was obtained as with serum-supplemented me-
dium, i.e., a strong dexamethasone/insulin enhancement
of BLV-LTR-CAT transcription.in the presence or absence of cycloheximide (10 mg/
ml), a potent inhibitor of protein synthesis. The results
Dexamethasone/insulin stimulation requires the
showed that the dexamethasone/insulin effect on mRNA
presence of glucocorticoid receptors
transcription was not reduced by cycloheximide (1.131
that of the control), suggesting that the hormone re- The role of glucocorticoid receptor (GR) in the viral re-
sponse to dexamethasone was explored using matchedsponse was at the level of transcription, rather than trans-
lation. To confirm that cycloheximide indeed blocked pro- GR-positive and GR-negative rat hepatoma cells lines de-
rived from the same parental line. These were transientlytein synthesis in Bat2Cl6 cells under these conditions,
a TCA precipitation experiment was performed, using cotransfected with BLV–LTR–CAT and BLV-tax plasmids
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types (Posner et al., 1974). A possible explanation for insu-
lin’s potentiation of dexamethasone’s effect can be found
in the work of Pan and Koontz (1995). Using synthetic
GRE-CAT constructs, they found that dexamethasone
stimulated maximal induction with three GRE’s per con-
struct. Insulin alone had no effect on expression of the
gene, but it acted in combination with dexamethasone to
stimulate CAT expression, causing a threefold increase
over dexamethasone alone. This insulin effect was partic-
ularly pronounced when only one GRE was present; the
more GREs there were in the promoter, the less was insu-
lin’s effect, implying that strong synergy between the two
hormones depended on there being a limited number of
DNA binding sites for glucocorticoid receptor.
Our results have shown that the dexamethasone stimu-
lation of BLV transcription we observed requires the pres-
ence of glucocorticoid receptors. This is consistent with
previously described glucocorticoid regulation of cellular
and viral genes (reviewed, Beato, 1989). Our finding, how-
FIG. 3. Effect of hormones on BLV transcription as measured by ever, that BLV Tax is also required was completely unex-
densiometric readings of the RNA blot depicted in Fig. 2. Values were
pected. Most genes that are hormone responsive, includ-normalized to actin levels. The BLV-infected cell line (Bat2Cl6) was
ing those of viruses, do not require additional transcrip-incubated under various hormone conditions. NH, no hormone; Dx,
dexamethasone; Ins, insulin; Prl, prolactin; Pg, progesterone;/, statisti- tional factors to mediate the responsiveness. It is unlikely
cally significant at P  0.05 when compared to the NH control (Dunnett that the dexamethasone/insulin effect was due to excess
t test). Error bars represent standard deviation from the mean of values Tax production from stimulation of the SV40 early promoter
from two separate experiments.
driving the tax construct. This promoter is not glucocorti-
coid-responsive and has, in fact, been used as a negative
control in studies on glucocorticoid-responsive promotersand assayed for CAT activity. In medium supplemented
(Hoeck et al., 1992). Moreover, the dexamethasone effectwith dexamethasone and insulin, the GR-negative line
EDR3 showed no elevation of CAT activity over its un-
treated control, whereas the GR-positive line BDS1
showed a significant increase in CAT activity (data not
shown). These experiments demonstrate that GR is neces-
sary for dexamethasone stimulation of the BLV-LTR.
DISCUSSION
This study has provided evidence that BLV is hormone
responsive. The most striking finding to emerge was the
stimulatory role of a glucocorticoid, dexamethasone, in
concert with insulin and prolactin, in the regulation of BLV
transcription. The combination of dexamethasone/insulin
resulted in a three- to fourfold increase of BLV expression
in the Bat2Cl6 cell line as measured by reverse tran-
scriptase assay (RT), RNA blotting, and CAT reporter
assays. Three other mammotropic hormones (prolactin,
insulin, and 17b-estradiol) tested singly did not stimulate
an increase in BLV particle production, gene transcription,
or LTR promoter function. Progesterone tested singly dem-
onstrated significant stimulation by two of the assays. This
FIG. 4. Effect of hormones on chloramphenicol acetyltransferaseis not surprising since progesterone receptor can utilize
(CAT) activity in Bat2Cl6 cells stably transfected with the BLV-LTR genethe GRE (Cato et al., 1987; Van der Ahe et al., 1985).
coupled to the CAT gene. NH, no hormone; E2, 17b-estradiol; Pg, pro-Although insulin appeared to enhance dexamethasone
gesterone; Prl, prolactin; Ins, insulin; Dx, dexamethasone; *, statistically
stimulation of BLV expression, insulin alone had no effect. significant at P  0.01, and /, at P  0.05 when compared to the NH
It is unlikely this was due to lack of receptors as insulin control (Dunnett t test). Error bars represent standard deviation from
the mean of triplicate values.binding activity has been demonstrated in most tissue
AID VY 8868 / 6a54$$$503 12-15-97 10:27:05 vira AP: VY
255HORMONE REGULATION OF BLV
TABLE 2 CAT without any source of Rex, from either an infecting
virus or a cotransfected Rex-expressing plasmid. It isEffect of Tax on CAT Activity in Transiently
also unlikely that Rex modulates transcription of the CATTransfected MCF-7 Cells
construct. Preliminary evidence from another study in our
CAT activity relative to laboratory suggested that the basal CAT activity (without
control without hormone Ratio hormones) for the BLV-infected Bat2Cl6 cell line trans-with Tax/
fected with the CAT plasmid was not significantly differ-Treatment Without Tax With Tax without Tax
ent from the basal CAT activity of the uninfected parental
17-b Estradiol 1.09 1.02 0.93 line of Bat2Cl6 (Tb1Lu) cotransfected with the CAT re-
Progesterone 0.87 0.88 1.00 porter plasmid plus the tax construct (and therefore, with
Insulin 1.31 1.00 0.76 no source of Rex) (Xiao and Buehring, manuscript in prep-
Prolactin 0.64 0.79 1.23
aration). These results are consistent with the findingsDexamethasone 1.40 2.17 1.54
of others that the regulatory action of Rex on the produc-Dexamethasone/insulin 2.82 8.49 3.00
tion of viral structural proteins may be primarily through
Note. All experiments were run in triplicate. posttranscriptional processing of messages rather than
at a transcriptional level (Derse, 1988; Powers and
Radke, 1992).was demonstrated in the BLV infected cell lines (Bat2Cl6
and FLK) containing no SV40 material. The most plausible In the RT assay the mixture of dexamethasone, insulin,
and prolactin substantially increased RT levels aboveexplanation for the effect of Tax is a synergy between
steroid–receptor complexes and other transcription fac- those of cells treated with dexamethasone/insulin only,
whereas mRNA transcription and BLV-LTR-CAT activitytors. There are precedents for this. One example occurs
in the retrovirus, human immunodeficiency virus (HIV). with the three hormones were less than that seen with
dexamethasone/insulin treatment. One possible explana-Kolesnitchenko and Snart (1992) demonstrated that HIV
was responsive to dexamethasone only when the viral tat tion for this discrepancy is that, while glucocorticoids can
act directly to stimulate BLV transcription, they might, inprotein was present. Like Tax, this protein is a transcrip-
tional activator of the viral LTR. The similarity of this situa- addition, stimulate viral replication indirectly through their
effect on the cell. The combination of glucocorticoids, in-tion with what we have described for BLV is striking.
A second example of synergy is the complex ‘‘glucocor- sulin, and prolactin stimulates differentiation of mammary
cells (Cowie et al., 1980). The differentiation state of hostticoid response unit,’’ which was identified in the phos-
phoenolpyvurate carboxylase (PEPCK) gene. This unit cells has been found to influence the expression of several
viruses, including MMTV, hepatitis B virus, dengue virus,consisted of two GREs and two accessory factor-binding
elements for AF-1 and AF-2, necessary for glucocorticoid cytomegalovirus, human papilloma virus, and HIV (Durban
et al., 1990; Galle et al., 1994; O’Sullivan and Killen, 1994;response of this gene (Imai et al., 1990). Protein interac-
tion between glucocorticoid receptor and CREB was ob- Poland et al., 1994; Stoler et al., 1989; Yahi et al., 1992). The
increased production of MMTV associated with mammaryserved, suggesting that the nearby CRE was also in-
volved in glucocorticoid response of the PEPCK gene cell differentiation is believed to be at the level of protein
synthesis and processing, not at the transcriptional level(Imai et al., 1993). CREB proteins activate the LTR regions
of BLV and HTLV at a low level without Tax, but in its (Durban et al., 1990).
The majority of our experiments were conducted usingpresence, this activation is enhanced (Kwok et al., 1996;
Willems et al., 1992). This interaction was shown to be the Bat2Cl6 line of bat lung epithelial cells. Neither the
species nor the tissue type from which this line origi-further modulated by protein kinase A in transient trans-
fection studies (Willems et al., 1992; Adam et al., 1996) nated is relevant to the natural history of BLV infection,
where only bovine lymphocytes, endothelial cells, andand protein kinase C in ex vivo expression studies (Kerk-
hofs et al., 1996). Cooperation between CREB and Tax mammary cells have been found to be targets of BLV
infection. It was necessary to use the bat cell line, how-has been discussed by others (Beimling and Moelling,
1992; Kiss-Toth et al., 1993), but steroid involvement in ever, in order to achieve the relatively high level of virus
production necessary to detect reverse transcriptase ac-transactivation of the BLV LTR has not been previously
described. It seems reasonable to suggest that ligand- tivity and BLV messenger RNA. We did not attempt these
experiments using primary cultures of lymphocytes in-bound glucocorticoid receptor might be another compo-
nent in the complex protein interactions involved in regu- fected in vivo because it has been reported that the level
of BLV replication by ex vivo lymphocytes is highly vari-lating this virus.
We did not specifically examine any role that the BLV able among different cows (Zandomeni et al., 1992) and
that ‘‘reproducibility . . . was unsatisfactory, even withregulatory protein, Rex, might have on expression of the
CAT reporter construct. Clearly, Rex was not required. supernatant fluids obtained simultaneously from dupli-
cate cultures of the same batch of lymphocytes’’ (GravesMCF-7 cells cotransfected with the reporter construct
and the Tax-producing construct were able to produce et al., 1977). Moreover, glucocorticoids are known to in-
AID VY 8868 / 6a54$$$504 12-15-97 10:27:05 vira AP: VY
256 NIERMANN AND BUEHRING
duce apoptotic death in lymphocytes (reviewed, Arends stein–Barr virus (9-fold) (Schuster et al., 1991). Several
of these viruses are known to contain GRE sequencesand Wylie, 1991). Although this has been studied most
extensively in T cells, B lymphocyte proliferation was also (Chandler et al., 1983; Gloss et al., 1987; Kolesnitchkenko
and Snart, 1992; Miksicek et al., 1986). Hormone respon-found to be inhibited, both in vivo (Bloom et al., 1979)
and in vitro (Cupps et al., 1985). These results suggest siveness has not, however, been previously reported in
any member of the HTLV/BLV subfamily, nor has a puta-that host cell destruction could compromise the quantita-
tive outcome of glucocorticoid studies with lymphocytes. tive GRE been identified. Our results, therefore, lay the
background for future studies to identify the precise re-For these reasons, the bat lung epithelial and human
mammary epithelial cells we have used for these studies gion of the BLV LTR that is glucocorticoid responsive
and to explore the possibility that other closely relatedwere appropriate choices. Our immunocytochemical
studies with primary cultures of in vivo infected bovine viruses, such as the HTLVs, might also be glucocorticoid
responsive.mammary epithelial cells are relevant to the natural his-
tory of BLV infection, and suggest that many of these
cells are silently infected and may be stimulated to viral ACKNOWLEDGMENTS
production by the addition of mammotropic hormones,
We thank Drs. Gary Firestone, John Forte, Satyabrata Nandi, Seanincluding glucocorticoids.
Philpott, Barry Shane, and Jianqiao Xiao for advice and support during
Hormone responsiveness of viruses may have evolved the course of this study. Special thanks are due to Anita Maiyer, Tinya
to enable the virus to exploit the hormonal state of the Abrams, and Carolyn Cover for their technical advice. This work was
funded in part by grants from Sigma Xi national and local chapters,host organism for its own survival. The virus would be
the Soroptimist International Founder Region, and the following Univer-able to time its replication to maximize transmission and
sity of California, Berkeley sources: School of Public Health Grossmanminimize its destruction by the host’s immune response.
Endowment, Howard Bern Research Award, Provost’s Research Fund,
For example, mammotropic oncogenic viruses could es- Group in Endocrinology, and Committee on Research Faculty Research
cape mechanisms of humoral immunity in a first-time Grants. G. Niermann was supported by a Soroptimist International
Founder Region Fellowship, and various fellowships from the Graduatemother by remaining latent in mammary cells until late
Division, University of California, Berkeley.pregnancy and parturition, when high blood levels of glu-
cocorticoids would stimulate rapid virus replication.
Transmission in mother’s milk to the offspring before the REFERENCES
mother’s immune system had had a chance to eliminate
Adam, E., Kerkhofs, P., Mammerickx, M., Burny, A., Kettman, R., and
the virus would insure passage of the virus to the next Willems, L. (1996). The CREB, ATF-1, and ATF-2 transcription factors
generation. Subsequent to delivery of the first-born, the from bovine leukemia virus-infected B lymphocytes activate viral ex-
pression. J. Virol. 70, 1990–1999.antibody levels might remain high enough to neutralize
Anderson, E., Selig, M., Lee, G-Y., and Little, B. (1988). In vitro study ofor suppress the virus, and transmission to subsequent
the effects of androgens on the cytoskeleton of ovarian granulosaoffspring might be less efficient.
cells with special reference to actin. Tiss. Cell 20, 855–874.
Hormone responsiveness via an LTR might play an ad- Arends, M. J., and Wylie, A. H. (1991). Apoptosis: Mechanisms and roles
ditional role in the development of cancer. Retroviral LTR in pathology. Int. Rev. Exp. Pathol. 32, 223–254.
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelein, B. L.,sequences might insert adjacent to a cellular oncogene,
Housman, D. E., and Evans, R. M. (1987). Cloning of human mineralo-rendering the cellular gene hormone responsive (re-
corticoid receptor complementary DNA: Structural and functional kin-viewed, Beato, 1989). Stress-induced, pregnancy-induced,
ship with the glucocorticoid receptor. Science 237, 268–275.
or iatrogenic glucocorticoids might then stimulate exces- Ball, J. K., Arthur, L. O., and Dekaban, G. A. (1985). The involvement of
sive transcription of that oncogene, leading to abnormal a type-B retrovirus in the induction of thymic lymphomas. Virology
140, 159–172.growth of the cell (Kolesnitchkenko and Snart, 1992).
Beato, M. (1989). Gene regulation by steroid hormones. Cell 56, 335–The combined evidence we have presented from re-
344.verse transcriptase, mRNA, and CAT reporter assays
Beimling, P., and Moelling, K. (1992). Direct interaction of CREB protein
supports the hypothesis that BLV is hormone regulated. with 21-bp tax-response elements of HTLV-I LTR. Oncogene 5, 257–
These studies have identified which of five mammotropic 262.
Blair, P. B. (1981). Immune responses to mammary tumor virus-inducedhormones tested have an effect and which do not. Gluco-
mammary tumors. In ‘‘Mechanisms of Immunity to Virus-Induced Tu-corticoid-induced BLV expression has been demon-
mors’’ (J. W. Blasceki, ed.), pp. 181–257. Dekker, New York, NY.strated and its requirement for functional glucocorticoid
Bloom, J. C., Kenyon, S. J., and Gabuzda, T. G. (1979). Glucocorticoid
receptors, and BLV Tax, and its enhancement by insulin effects on peripheral blood lymphocytes in cows infected with bovine
has been established. The 3- to 4-fold strength of this leukemia virus. Blood 53, 899–912.
Bolander, F. F., and Blackstone, M. E. (1990). Developmental and hor-glucocorticoid induction is consistent with that demon-
monal regulation of a mouse mammary tumour virus glycoprotein instrated for other viruses: MMTV (3- to 16-fold) (Chandler
normal mouse mammary epithelium. J. Mol. Endocrin. 4, 101–106.et al., 1983), Moloney murine sarcoma virus (2- to 6-fold)
Buehring, G. C., Kramme, P. M., and Schultz, R. D. (1994). Evidence for
(Miksicek et al., 1986), human papilloma virus-16 (4-fold) bovine leukemia virus in mammary epithelial cells of infected cows.
(Gloss et al., 1987), human immunodeficiency virus type Lab. Invest. 71, 359–365.
Burridge, M. J., Thurmond, M. C., Miller, J. M., Schmerr, M. J. F., and VanI (1.49-fold) (Kolesnitchkenko and Snart, 1992), and Ep-
AID VY 8868 / 6a54$$$504 12-15-97 10:27:05 vira AP: VY
257HORMONE REGULATION OF BLV
Der Maaten, M. J. (1982). Fall in antibody titer to bovine leukemia Horwitz, K. B., Costlow, M. E., and McGuire, W. L. (1975). MCF-7: A
human breast cancer cell line with estrogen, androgen, progester-virus in the periparturient period. Can. J. Compar. Med. 46, 270–271.
Cardiff, R. D., Young, L. J. T., and Ashley, R. L. (1976). Hormone syner- one, and glucocorticoid receptors. Steroids 26, 785–795.
Imai, E., Stromstedt, P. E., Quinn, P. G., Carlstedt-Duke, J., Gustafsson,gism in the in vitro production of the mouse mammary tumor virus.
J. Toxicol. Env. Health 1(Suppl.), 117–129. J. A., and Granner, D. K. (1990). Characterization of a complex gluco-
corticoid response unit in the phosphoenolpyruvate carboxykinaseCato, A. C. B., Henderson, D., and Ponta, H. (1987). The hormone re-
sponse element of the mouse mammary tumor virus DNA mediates gene. Mol. Cell. Biol. 10, 4712–4719.
Imai, E., Miner, J. N., Mitchell, J. A., Yamamoto, K. R., and Granner, D. K.the progestin and estrogen induction of transcription in the proviral
long terminal repeat region. EMBO J. 6, 363–368. (1993). Glucocorticoid receptor-cAMP response element-binding pro-
tein interaction and the response of the phosphoenolpyruvate car-Chandler, V. L., Maier, B. A., and Yamamoto, K. R. (1983). DNA sequences
bound specifically by glucocorticoid receptor in vitro render a heterolo- boxykinase gene to glucocorticoids. J. Biol. Chem. 268, 5353–5356.
Kerkhofs, P., Adam, E., Droogmans, L., Portetelle, D., Mammerickx, M.,gous promoter hormone responsive in vivo. Cell 33, 489–499.
Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA Burny, A., Kettman, R., and Willems, L. (1996). Cellular pathways
involved in the ex vivo expression of bovine leukemia virus. J. Virol.isolation by acid guanidium thyocyanate-phenol-chloroform extrac-
tion. Anal. Biochem. 162, 156 –159. 70, 2170–2177.
Kettman, R., Burny, A., Callebaut, I., Droogmans, L., Mammerickx, M.,Cicatiello, L., Ambrosino, C., Coletta, B., Scalona, M., Sica, V., Bresciani,
F., and Weicz, A. (1992). Transcriptional activation of jun and actin Willems, L., and Portetelle, D. (1994). Bovine leukemia virus. In ‘‘The
Retroviridae’’ (J. A. Levy, ed.), Vol. 3. Plenum, New York, NY.genes by estrogen during mitogen stimulation of rat uterine cells. J.
Steroid Biochem. Mol. Biol. 41, 523–528. Kiss-Toth, E., Saowakon, P., Unk, I., and Boros, I. (1993). A member of
the CREB/ATF protein family, but not CREBa, plays an active role inCook, P. W., Swanson, K. T., Edwards, C. P., and Firestone, G. L. (1988).
Glucocorticoid receptor-dependent inhibition of cellular proliferation the BLV tax transactivation in vivo. Nucleic Acids Res. 21, 3677–
3682.in dexamethasone-resistant and hypersensitive rat hepatoma cell
variants. Mol. Cell. Biol. 8, 1449–1459. Kolesnitchenko, V., and Snart, R. S. (1992). Regulatory elements in the
human immunodeficiency virus type 1 long terminal repeat LTR (HIV-Cowie, A. T., Forsyth, I. A., and Hart, I. C. (1980). ‘‘Hormonal Control of
Lactation,’’ pp. 86, 95. Springer-Verlag, New York, NY. 1) responsive to steroid hormone stimulation. AIDS Res. Hum. Retro-
viruses 8, 1977–1980.Cupps, T. R., Gerrard, T. L., Falko, J. M. (1985). Effects of in vitro cortico-
steroids on B cell activation, proliferation, and differentiation. J. Clin. Kramme, P. M., Thomas, C. B., and Schultz, R. D. (1994). Contribution
of bovine leukemia virus-infected B cells to the number of circulatingInvest. 75, 754–761.
Derse, D. (1988). trans-activating regulation of bovine leukemia virus B cells in cattle. Comp. Haematol. Intl. 4, 96–101.
Kuzmak, J. (1988). Bovine leukemia virus antibody levels in the bloodmRNA processing. J. Virol. 62, 1115–1119.
Durban, E. M., Knepper, J. E., Medina, D., and Butel, J. S. (1990). Influ- and mammary gland secretions in cows in the perinatal period. Pol.
Arch. Weter. 28, 63–73.ence of mammary cell differentiation on the expression of proteins
encoded by endogenous BALB/c mouse mammary tumor virus Kwok, R. P. S., Laurance, M. E., Lundblad, J. R., Goldman, P. S., Shih,
H-M., Conner, L., Marriott, S. J., and Goodman, R. H. (1996). Controlgenes. Virus Res. 16, 307 – 323.
Ebertus, R., Starick, E., and Wittmann, W. (1987). Titer changes in anti- of cAMP-regulated enhancers by the viral transactivator Tax through
CREB and the co-activator CBP. Nature 380, 642–646.bodies against the bovine leukosis virus in blood serum and in udder
secretions in cows and heifers during the perinatal period. Arch. Lee, M. H., Sano, K., Morales, F. E., and Imagawa, D. T. (1987). Sensitive
reverse transcriptase assay to detect and quantitate human immuno-Exp. Vet. 41, 732–737.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, deficiency virus. J. Clin. Microbiol. 25, 1717–1721.
McGrath, C. M. (1971). Replication of mammary tumor virus in tumorM., Northrop, J. P., Ringold, G. M., and Danielson, M. (1987). Lipofec-
tion: A highly efficient, lipid-mediated DNA-transfection procedure. cell cultures: Dependence on hormone-induced cellular organization.
J. Natl. Cancer Inst. 47, 455–467.Proc. Natl. Acad. Sci. USA 84, 7413–7417.
Galle, P. R., Hagelstein, J., Kommerell, B., Volkmann, M., Schranz, P., McGrath, M. F. (1987). A novel system for mammary epithelial cell cul-
ture. J. Dairy Sci. 70, 1967–1980.and Zentgraf, H. (1994). In vitro experimental infection of primary
human hepatocytes with hepatitis B virus. Gastroenterology 106, Miksicek, R., Heber, A., Schmid, W., Danesch, U., Posseckert, G., Beato,
M., and Schu¨tz, G. (1986). Glucocorticoid responsiveness of the tran-664– 673.
Gloss, B., Bernard, H. U., Seedorf, K., and Klock, G. (1987). The upstream scriptional enhancer of Moloney murine sarcoma virus. Cell 46, 283–
290.regulatory region of the human papilloma virus-16 contains an E2
protein-independent enhancer which is specific for cervical carci- Mun˜oz, B., and Bolander, F. F. (1989). Prolactin regulation of mouse
mammary tumor virus (MMTV) expression in normal mouse mam-noma cells and regulated by glucocorticoid hormones. EMBO J. 6,
3735–3743. mary epithelium. Mol. Cell. Endocrinol. 62, 23–29.
Nagle, S. C., and Fine, D. L. (1978). Demonstration of components ofGraves, D. C., and Ferrer, J. F. (1976). In vitro transmission and propaga-
tion of the bovine leukemia virus in monolayer cell cultures. Cancer serum-free culture medium affecting maximum in vitro expression of
mouse mammary tumor virus. In Vitro 14, 218–226.Res. 36, 4152–4159.
Graves, D. C., Diglio, C. A., and Ferrer, J. F. (1977). A reverse tran- O’Sullivan, M. A., and Killen, H. M. (1994). The differentiation state of
monocytic cells affects their susceptibility to the infection and thescriptase assay for detection of the bovine leukemia virus. Am. J.
Vet. Res. 38, 1739– 1744. effects of the infection by dengue virus. J. Gen. Virol. 75, 2392–2397.
Pan, L., and Koontz, J. (1995). Insulin enhances glucocorticoid receptor-Heeney, J. L., and Valli, V. E. (1990). Transformed phenotype of enzootic
bovine lymphoma reflects differentiation-linked leukemogenesis. mediated induction of gene expression independent of a specific
insulin response element. Arch. Biochem. Biophys. 316, 886–892.Lab. Invest. 62, 339 – 346.
Hoeck, W., Hofer, P., and Groner, B. (1992). Overexpression of the Parks, W. P., Scolnick, E. M., and Kozikowski, E. H. (1974). Dexametha-
sone stimulation of murine mammary tumor virus expression: A tis-glucocorticoid receptor represses transcription from hormone re-
sponsive and nonresponsive promoters. J. Steroid Biochem. Mol. sue culture source of virus. Science 184, 158–160.
Payvar, F., DeFranco, D., Firestone, G. L., Edgar, B., Wrange, O¨., Okret,Biol. 41, 283–289.
Hoffman, A. D., Banapour, B., and Levy, J. A. (1985). Characterization S., Gustafsson, J. A˚., and Yamamoto, K. R. (1983). Sequence-specific
binding of the glucocorticoid receptor to MTV-DNA at sites withinof the AIDS-associated retrovirus reverse transcriptase and optimal
conditions for its detection in virions. Virology 147, 326–335. and upstream of the transcribed region. Cell 35, 381–392.
AID VY 8868 / 6a54$$$505 12-15-97 10:27:05 vira AP: VY
258 NIERMANN AND BUEHRING
Poland, S. D., Bambrick, L. L., Dekaban, G. A., and Rice, G. P. (1994). L. T. (1989). Differentiation-linked human papilloma virus types 6 and
11 transcription in genital condylomata revealed by in situ hybridiza-The extent of human cytomegalovirus replication in primary neurons
is dependent on host cell differentiation. J. Infect. Dis. 170, 1267– tion with message-specific RNA probes. Virology 172, 331–340.
Stott, M. L., Thurmond, M. C., Dunn, S. J., Osburn, B. L., and Stott, J. L.1271.
Posner, B. I., Kelly, P. A., Shiu, R. P., and Friesen, H. (1974). Studies of (1991). Integrated bovine leukosis proviral DNA in T helper and T
cytotoxic/suppressor lymphocytes. J. Gen. Virol. 72, 307–315.insulin, growth hormone and prolactin binding: Tissue distribution,
species variation and characterization. Endocrinology 95, 521–531. Topper, Y. J., and Freeman, C. S. (1980). Multiple hormone interactions
in the developmental biology of the mammary gland. Physiol. Rev.Powers, M. A., and Radke, K. (1992). Activation of bovine leukemia virus
transcription in lymphocytes from infected sheep: Rapid transition 60, 1049–1106.
Van der Ahe, D., Janich, S., Scheidereit, C., Renkawitz, R., Schu¨rtz, G.,through early to late gene expression. J. Virol. 66, 4769–4777.
Ringold, G. M., Yamamoto, K. R., Tomkins, G. M., Bishop, J. M., and Var- and Beato, M. (1985). Glucocorticoid and progesterone receptors
bind to the same sites in two hormonally regulated promoters. Naturemus, H. E. (1975). Dexamethasone-mediated induction of mouse
mammary tumor virus RNA: A system for studying glucocorticoid 313, 706–709.
Van Der Maaten, M. J., and Miller, J. M. (1976). Replication of bovineaction. Cell 6, 299– 305.
Rovnak, J., Casey, J. W., Boyd, A. L., Gonda, M. A., and Cockerell, G. L. leukemia virus in monolayer cell cultures. Intl. J. Cancer 31, 791.
Willems, L., Heremans, H., Chen, G., Portetelle, D., Billiau, A., Burny,(1991). Isolation of bovine leukemia virus infected endothelial cells
from cattle with persistent lymphocytosis. Lab. Invest. 65, 192–202. A., and Kettmann, R. (1990). Cooperation between bovine leukemia
virus transactivator protein and Ha-ras oncogene product in cellularSambrook, J., Fritsch, E. L., and Maniatis, T. (1989). ‘‘Molecular Cloning:
A Laboratory Manual,’’ 2nd ed. Cold Spring Harbor Laboratory Press, transformation. EMBO J. 9, 1577–1581.
Willems, L., Kettmann, R., Chen, G., Portetelle, D., Burny, A., and Derse,Cold Spring Harbor, NY.
Schuster, C., Chasserot-Golaz, S., and Beck, G. (1991). Activation of D. (1992). A cyclic AMP-responsive DNA-binding protein (CREB2) is
a cellular transactivator of the bovine leukemia virus long terminalEpstein–Barr virus promoters by a growth-factor and a glucocorti-
coid. FEBS Lett. 284, 82 – 86. repeat. J. Virol. 66, 766–772.
Yahi, N., Baghdiguian, S., Bolmont, C., and Fantini, J. (1992). ReplicationSmoller, C. G., Pitelka, D. R., and Bern, H. A. (1961). Cytoplasmic inclu-
sion bodies in cortisol-treated mammary tumors of C3H/Crgl mice. and apical budding of HIV-1 in mucous-secreting colonic epithelial
cells. J. Acquired Immune Deficiency Syndromes 5, 993–1000.J. Biophys. Biochem. Cytol. 9, 915–920.
Soule, H. D., Vazquez, J., Long, A., Albert, S., and Brennan, M. (1973). Yang, J., Enami, I., and Nandi, S. (1977). Regulation of mammary tumor
virus production by prolactin in BALB/cfC3H mouse normal mammaryA human cell line from a pleural effusion derived from a breast
carcinoma. J. Natl. Cancer Inst. 51, 1409–1413. epithelial cells in vitro. Cancer Res. 37, 3644–3647.
Zandomeni, R. O., Carrera-Zandomeni, M., Esteban, E., Donawick, W.,Southern, P. J., and Berg, P. (1982). Transformation of mammalian cells
to antibiotic resistance with a bacterial gene under control of the and Ferrer, J. F. (1992). Induction and inhibition of bovine leukaemia
virus expression in naturally infected cells. J. Gen. Virol. 73, 1915–SV40 promoter. J. Mol. Appl. Genet. 1, 327–341.
Stoler, M. H., Wolinsky, S. M., Whitbeck, A., Broker, T. R., and Chow, 1924.
AID VY 8868 / 6a54$$$505 12-15-97 10:27:05 vira AP: VY
